PMGC Holdings ELAB
NASDAQ ELAB
$4.70 +0.08 (+1.72%)
As of: Sep 10, 2026 · 12:55 PM EDT

PMGC Holdings (ELAB) Total Liabilities (2022 - 2026)

PMGC Holdings' (ELAB) quarterly Total Liabilities came in at $19.8 million in Q2 2026, up 5976.47% year-over-year from $326301.0 in Q2 2025, and up 47.67% quarter-over-quarter from $13.4 million in Q1 2026.

Analysis

PMGC Holdings (ELAB) Total Liabilities (2022 - 2026) Analysis & Trends

PMGC Holdings has disclosed Total Liabilities across 5 years of filings, most recently posting $19.8 million for Q2 2026.

  • In Q2 2026, Total Liabilities rose 5976.47% year-over-year to $19.8 million; the TTM figure through Jun 2026 stood at $19.8 million (up 5976.47% YoY), while the FY2025 annual figure was $5.0 million, up 115.59% from the prior year.
  • Total Liabilities came in at $19.8 million for Q2 2026 at PMGC Holdings, up from $13.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $1.7 billion in Q3 2023 to a low of -$1.6 billion in Q3 2022.
  • Average Total Liabilities over 5 years is $11.5 million, with a median of $2.0 million recorded in 2024.
  • Year-over-year, Total Liabilities slumped 99.85% in 2024 and jumped 5976.47% in 2026.
  • Over 5 years, Total Liabilities stood at $760873.0 in 2022, then soared by 79.12% to $1.4 million in 2023, then surged by 71.23% to $2.3 million in 2024, then jumped by 115.59% to $5.0 million in 2025, then jumped by 294.1% to $19.8 million in 2026.
  • Per Business Quant data, the three most recent Total Liabilities figures were $19.8 million in Q2 2026, $13.4 million in Q1 2026, and $5.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Amgen 206.40 Bn 192.42 Bn 7.24 Bn 83.95 Bn
2 Gilead Sciences 180.38 Bn 177.20 Bn 6.22 Bn 37.53 Bn
3 Vertex Pharmaceuticals 131.28 Bn 123.43 Bn 2.84 Bn 7.18 Bn
4 Regeneron Pharmaceuticals 81.73 Bn 73.73 Bn 3.93 Bn 10.02 Bn
5 Argenx Se 60.28 Bn 55.09 Bn 1.37 Bn 1.62 Bn
6 Moderna 54.02 Bn 48.88 Bn 52.00 Mn 4.20 Bn
7 Alnylam Pharmaceuticals 33.28 Bn 29.97 Bn 992.69 Mn 4.20 Bn
8 Biogen 31.81 Bn 30.52 Bn 1.96 Bn 13.24 Bn
9 Roivant Sciences 29.02 Bn 29.02 Bn 1.16 Mn 384.62 Mn
10 PMGC Holdings 2.29 Mn -16.50 Mn 385,691.00 19.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.83 Mn
Mar 31, 2026 13.43 Mn
Dec 31, 2025 5.03 Mn
Sep 30, 2025 6.45 Mn
Jun 30, 2025 326,301.00
Mar 31, 2025 760,268.00
Dec 31, 2024 2.33 Mn
Sep 30, 2024 2.65 Mn
Jun 30, 2024 2.44 Mn
Mar 31, 2024 1.74 Mn
Dec 31, 2023 1.36 Mn
Sep 30, 2023 1.75 Bn
Jun 30, 2023 -67,288.00
Mar 31, 2023 -913,388.00
Dec 31, 2022 760,873.00
Sep 30, 2022 -1.62 Bn